5-amino-1-(4-chlorophenyl)-1,5-dihydro-4H-pyrazolo[3,4-d]pyrimidin-4-one, 95.0%, 500mg

4-CHLORO-8-ISOPROPYL-2-METHYLSULFANYL-PYRAZOLO[1,5-A][1,3,5]TRIAZINE, 90.0%, 5g

1-Bromo-3-methylbutane>96.0%(GC)25g

(2-Oxabicyclo[2.2.2]octan-1-yl)methanol, 97%, 100mg

(1?,8?,9?)-Bicyclo[6.1.0]non-4-yn-9-ylmethanol, 90.0%, 25mg

Lead(II) nitrate, min. 99%, PA, ACS, 250 g, plastic packaging.

Methyl 2-((3S,4R)-4-aminopyrrolidin-3-yl)acetate bis(4-methylbenzenesulfonate), 95%, 250mg

(S)-1-(4-(Difluoromethoxy)phenyl)ethan-1-amine hydrochloride, 95%, 250mg

5-Bromo-2-(1H-pyrazol-1-yl)pyridine, 95.0%, 1g

[(2E)-3-(4-methoxyphenyl)prop-2-en-1-yl](prop-2-en-1-yl)amine, 95.0%, 2g

1-((2R,3R,4R)-4-((tert-butyldimethylsilyl)oxy)-3-fluoro-5,5-bis(hydroxymethyl)tetrahydrofuran-2-yl)pyrimidine-2,4(1H,3H)-dione, 98%, 250mg

8-BROMO-2'-DEOXYADENOSINE, 95.0%, 250mg

2-Cyano-N-(2-hydroxyethyl)acetamide, 97.0%, 25g